Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2
Manisha Ray, Saurav Sarkar, Surya Narayan Rath
Genomics Inform. 2020;18(4):e43  Published online 2020 Dec 9     DOI: https://doi.org/10.5808/GI.2020.18.4.e43
Citations to this article as recorded by Crossref logo
In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein
Mohd Fardeen Husain Shahanshah, D. Anvitha, Vandana Gupta
Physics and Chemistry of the Earth, Parts A/B/C.2022; 127: 103188.     CrossRef
Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication
Ting Cai, Zhenbao Yu, Zhen Wang, Chen Liang, St├ęphane Richard
Journal of Biological Chemistry.2021; 297(1): 100821.     CrossRef
Bioinformatics Accelerates the Major Tetrad: A Real Boost for the Pharmaceutical Industry
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Saurabh Bhatia, Ahmed Al-Harrasi, Gokhan Zengin, Elena Emilia Babes, Ciprian Brisc, Manuela Stoicescu, Mirela Marioara Toma, Cristian Sava, Simona Gabriela Bungau
International Journal of Molecular Sciences.2021; 22(12): 6184.     CrossRef
Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications
Zeyu Sun, Xiaoqin Zheng, Feiyang Ji, Menghao Zhou, Xiaoling Su, Keyi Ren, Lanjuan Li
Infectious Microbes and Diseases.2021; 3(3): 149.     CrossRef